Amneal Pharmaceuticals, Inc. (AMRX)

17.54USD -2.61% (-0.47)

Over 1M: -4.3%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

17 18
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Operating Income: 75.6M Q3 '23 — Free Cash Flow: 69.7M Q4 '23 — Operating Income: 14.2M Q4 '23 — Free Cash Flow: 126M Q1 '24 — Operating Income: -10.7M Q1 '24 — Free Cash Flow: -13.6M Q2 '24 — Operating Income: 95.5M Q2 '24 — Free Cash Flow: 29M Q3 '24 — Operating Income: 88.8M Q3 '24 — Free Cash Flow: 124.8M Q4 '24 — Operating Income: 75.8M Q4 '24 — Free Cash Flow: 102.9M Q1 '25 — Operating Income: 100.3M Q1 '25 — Free Cash Flow: -5.8M Q2 '25 — Operating Income: 111.4M Q2 '25 — Free Cash Flow: 61M Q3 '25 — Operating Income: 70.3M Q3 '25 — Free Cash Flow: 106.2M Q4 '25 — Operating Income: 112M Q4 '25 — Free Cash Flow: 108.5M Q1 '26 — Operating Income: 141.8M Q1 '26 — Free Cash Flow: -34.9M Q2 '26 — Operating Income: 129.8M Q2 '26 — Free Cash Flow: -51.9M -40M 0 40M 80M 120M 160M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Operating Income Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.4
Oper. margin 14.6%
ROIC 14.4%
OE margin 3.0%
Accruals -1.1%
ROCE 15.7%
ROE 476.5%
ROA 4.2%
Gross margin 39.3%
FCF margin 4.1%
OCF margin 6.4%
OCF / EBIT 0.44×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.3
EV/EBIT 17.7×
EV/OE 87.1×
EV/GP 6.6×
EV/Sales 2.6×
FCF yield 2.3%
P/E 35.5×
P/B 169.2×
P/C 43.8×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.0
Segment HHI 0.52 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.4
ND/EBITDA -0.3
Payout 0.0%
F-score 7.0 pts
Quick ratio 1.4×
Cash / Debt 0.05×
Debt / Eq 78.0×
Debt payback 19.2 yr
Net debt / Eq 74.1×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.1
Sales/sh Y/Y +3.9%
EPS Y/Y +4335.3%
EBIT Y/Y +20.6%
Sales Q/Q +9.9%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.